According to a recent CRO Oversight Benchmark Survey, 90% of ClinOps leaders plan to increase their use of CROs in the coming year, yet only 22% felt confident that their CROs would achieve milestones on time.
With impending changes necessary to address ICH E6 (R2), oversight is top of mind and requires sponsors to proactively answer questions such as:
- “Is my vendor doing what I hired them to do?”
- “Is the CRO adhering to my quality plan?”
- “Is the CRO’s performance meeting our expectations?”
- “What issues should we be escalating?”
Access Out-of-the-Box Features in 4 Weeks—Guaranteed.
Saama can put you on the fast track to clinical trial process innovation.